Terumo Corporation (Head Office: Shibuya-ku, Tokyo, Japan; President  and CEO: Yutaro Shintaku) announced today the creation in April 2016 of the  Terumo Fellow Program. The program is set up to recognize and appoint as "Terumo  Fellows", associates with expertise and experience in their fields, and who  have made outstanding contributions leading to innovation in medical settings  and technology, research, and clinical development.
            Four individuals have been  appointed as the first Terumo Fellows.
Terumo has established its Global  Vision as "Innovating at the Speed of Life," with the aim of  achieving further innovation for the benefit of medical professionals and the  lives of patients. Terumo will continue to pursue research and development that  will produce innovation that benefits healthcare throughout the world.
Terumo  Fellows 
Atsuhiko Nogawa
            Vice President, CV Division R&D, Cardiac and Vascular Company,  Terumo Corporation
            Outstanding Achievements:
 
Hiroyuki Yagami
Chief  Researcher, TIS Division R&D, Cardiac and Vascular Company, Terumo  Corporation 
          Outstanding Achievements:
Developed  the first intravascular coronary ultrasound diagnosis device produced in Japan
Developed  sensors, catheters, and materials for use with intravascular coronary ultrasound  diagnosis
 
Dennis Hlavinka
            Director  of Engineering, Terumo BCT, Inc. 
            Outstanding Achievements:
 
Dragica Paunovic, M.D.  
Chief  Medical Officer, Vice president Clinical, Terumo EMEA 
            Outstanding Achievements:
Led the global deployment of  medical device technologies developed in Japan, especially by initiating and  conducting early and late stage clinical trials in Europe and other continents.
Enabled global deployment of  interventional systems products including drug-eluting stents and OFDI (Optical  Frequency Domain Imaging) instruments, and many others.
 
              
(Notice) Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information        available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those        forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo,      fluctuations of foreign exchange rates, and state of competition. The market share information in this press release is partly derived from our own independent research.